These findings imply that BPC 157 may support intracellular signaling through post-translational modification rather than protein synthesis
What testing information is available for BPC-157
Summary: Both methylcobalamin and cyanocobalamin effectively treat B12 deficiency, with cyanocobalamin being more stable and cost-effective whilst methylcobalamin is bioactive without requiring conversion
Discover the research Description BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a partial sequence of human gastric juice protein
Research published in the British Journal of Pharmacology demonstrated that molecular conjugation of B12 (specifically the corrin ring structure found in cyanocobalamin) with GLP-1 receptor agonists produced a compound that was not as readily absorbed into the brainstem areas responsible for triggering nausea
Guertin DA, Stevens DM, Saitoh M, Kinkel S, Crosby K, Sheen JH, et al
